USPTO serial 79214859
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel M. Gurfinkel
Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Blood test kits and biochemical test kits comprised of medical diagnostic reagents for medical, diagnostic and veterinary use ] | SECTION 71 - CANCELLED | — |
| 009 | [ Automatic testing and analyzing apparatus and instruments, namely, autoloaders, differential hematology analyzers, analyzer automation and integration systems, coagulation screeners, cell image analyzers, blood glucose analyzers, and automated blood smearing instruments, used in the fields of hematology, biochemistry, immunology and coagulation for blood, urine and other biological samples other than for medical use; computer software and programs to automate to test and analyze blood, urine and other biological samples other than for medical use; computer software to digitize measured results for blood, urine and other biological samples other than for medical use; testing and analyzing apparatus and instruments, namely, autoloaders, differential hematology analyzers, analyzer automation and integration systems, coagulation screeners, cell image analyzers, blood glucose analyzers, automated blood smearing instruments, and their structural parts, used in the fields of hematology, biochemistry, immunology and coagulation for support of test and analysis for blood, urine and other biological samples other than for medical use; computer software and programs for support of testing and analysis for blood, urine and other biological samples other than for medical use; biochemistry analyzers and their structural parts used in the fields of hematology, biochemistry, immunology and coagulation, not for medical use; biochemistry testing apparatus and instruments, namely, autoloaders, differential hematology analyzers, analyzer automation and integration systems, coagulation screeners, cell image analyzers, blood glucose analyzers, automated blood smearing instruments, and their structural parts, used in the fields of hematology, biochemistry, immunology and coagulation, not for medical use; measuring apparatus and instruments for biochemistry used in the fields of hematology, biochemistry, immunology and coagulation ] | SECTION 71 - CANCELLED | — |
| 010 | [ Medical apparatus and instruments, namely, autoloaders, differential hematology analyzers, analyzer automators and integraters, coagulation screeners, cell image analyzers, blood glucose analyzers, and automated blood smearing instruments, used in the fields of hematology, biochemistry, immunology and coagulation; medical apparatus and instruments, namely, autoloaders, differential hematology analyzers, analyzer automators and integraters, coagulation screeners, cell image analyzers, blood glucose analyzers, and automated blood smearing instruments, to automatically test and analyze and for use in the fields of hematology, biochemistry, immunology, and coagulation for blood, urine and other biological samples for medical use; medical apparatus and instruments, namely, autoloaders, differential hematology analyzers, analyzer automators and integraters, coagulation screeners, cell image analyzers, blood glucose analyzers, automated blood smearing instruments, and their structural parts, for the support of testing and analysis used in the fields of hematology, biochemistry, immunology and coagulation for blood, urine and other biological samples for medical use; biochemistry analyzers and their structural parts used in the fields of hematology, biochemistry, immunology and coagulation for medical use; biochemistry testing apparatus and instruments, namely, autoloaders, differential hematology analyzers, analyzer automators and integraters, coagulation screeners, cell image analyzers, blood glucose analyzers, automated blood smearing instruments, and their structural parts, used in the fields of hematology, biochemistry, immunology and coagulation for medical use ] | SECTION 71 - CANCELLED | — |
| 037 | [ Repair or maintenance services for testing and analyzing apparatus and instruments for support of testing and analysis for blood, urine and other biological samples; repair or maintenance services for medical apparatus and instruments for support of testing and analysis for blood, urine, and other biological samples; repair or maintenance services for biochemistry analyzers; repair or maintenance services for measuring apparatus and instruments; repair or maintenance services for medical apparatus and instruments; sterilization services of medical apparatus ] | SECTION 71 - CANCELLED | — |
| 042 | Designing, namely, engineering services or graphic design services pertaining to machines, apparatus, and instruments or systems composed of such machines, apparatus, and instruments for testing and analyzing blood, urine and other biological samples; computer software design, computer programming, and maintenance of computer software and programs relating to testing and analyzing blood, urine and other biological samples; technological advice, namely, engineering advice, computer programming advice, and technology advice provided to customers via telephone, in person, and over computer networks, with such advice relating to computers and industrial machines for testing and analyzing blood, urine and other biological samples; providing temporary use of online non-downloadable computer software and programs used in the fields of hematology, biochemistry, immunology and coagulation relating to testing and analyzing blood, urine and other biological samples; providing technology information relating to testing and analyzing apparatus and instruments used to test and analyze blood, urine, and other biological samples; advisory services and consultancy relating to technology information for testing and analyzing apparatus and instruments used to test and analyze blood, urine, and other biological samples; repair, maintenance and support services, namely, troubleshooting of computer software problems or diagnosing software problems for computer software and programs for use in the field of medical testing and analysis of blood, urine, and other biological samples | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 12, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 8, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 8, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 8, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| May 5, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 30, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 29, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 7, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 18, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 18, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 29, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 29, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 9, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 24, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 24, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 24, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 5, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 4, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 4, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 4, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 4, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 4, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 18, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 2, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 1, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2017 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Oct 16, 2017 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Sep 22, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 18, 2017 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Sep 15, 2017 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 1, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 1, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 30, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 29, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 25, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 24, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |